Planning For Adaptability in Design

Whether you’re an integrator, a designer or simply a label-defying creative, the experience is everything. Host Bryan Meszaros explores the story behind the exhibit to understand how a carefully crafted experience traps into the human experience to connect people to place.

 

Design is much more than static. In the 21st-century is all about experience and shaping environments. To discuss the evolution, Experience by Design host Bryan Meszaros spoke with John Lutz, Partner at Selbert Perkins Design.

Lutz always loved art and turned that into a career while studying at the University of Cincinnati. The program was unique, allowing him to alternate between internships and school. These internships allowed him to experience different types of firms. In one internship, he worked on the FedEx rebranding and was part of the team behind the iconic arrow logo. Those experiences helped him decide he wanted to work for Selbert Perkins because they focused on experiential branded environments. “The idea of shaping an entire environment was very appealing to me,” he said.

“You have to plan for adaptability in your design. Technology changes, and so do the expectations of those in the spaces.” – John Lutz

Since then, he’s worked on projects for some of the most well-known places, including the Dallas Cowboys stadium, McCarren airport in Las Vegas, and the St. Louis Cardinals ballpark.

Lutz was witness to the transformation of static design to digital being a part of it. “When digital came into the fold, it was like we can put a screen here,” he noted.

There was an opportunity for dynamic changing content, but not much else until the evolution of screens, ideas, and configurations. “Over time, we could integrate digital into the art. The digital actually became art,” Lutz added.

Much of the firm’s initial work was in wayfinding and gateways. Now, he’s involved in the two worlds merging, bringing imagination, a sculptural approach, and visual drama. Lutz also spoke about environments being timeless but components being changeable. “You have to plan for adaptability in your design. Technology changes, and so do the expectations of those in the spaces.”

Join host Bryan Meszaros on Experience by Design every other Wednesday as he explores the latest trends and solutions helping craft the world’s most intriguing experiences.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More